WallStreetZenWallStreetZen

NASDAQ: MURA
Mural Oncology PLC Stock Ownership - Who owns Mural Oncology?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Mural Oncology PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Vicki L. GoodmanChief Medical Officer2025-11-105,036$2.08
$10.47kSell
Adam D. CutlerChief Financial Officer2025-11-037,148$2.09
$14.94kSell
Maiken KesonbrookesChief Legal Officer and Secretary2025-07-222,572$2.48
$6.38kSell
Maiken KesonbrookesChief Legal Officer and Secretary2025-07-182,158$2.48
$5.35kSell
Caroline LoewChief Executive Officer2025-07-0712,531$2.43
$30.48kSell
Maiken KesonbrookesChief Legal Officer and Secretary2025-03-051,469$3.45
$5.07kSell
Maiken KesonbrookesChief Legal Officer and Secretary2025-03-041,262$3.36
$4.24kSell
Caroline LoewChief Executive Officer2025-03-044,313$3.36
$14.49kSell
Vicki L. GoodmanChief Medical Officer2025-02-2413,186$3.89
$51.29kSell
Maiken KesonbrookesChief Legal Officer and Secretary2024-12-232,555$3.27
$8.35kSell

1 of 2

MURA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MURA insiders and whales buy or sell their stock.

MURA Shareholders

What type of owners hold Mural Oncology PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Trium Capital LLP10.15%1,760,097$3.70MInsider
Orbimed Advisors LLC3.39%588,800$1.24MInstitution
Newtyn Management LLC3.01%522,919$1.10MInstitution
Omers Administration Corp2.95%511,000$1.07MInstitution
Vanguard Group Inc2.62%454,712$954.90kInstitution
Rangeley Capital LLC1.76%305,000$640.50kInstitution
Caroline Loew1.69%293,059$615.42kInsider
Blackrock Inc1.66%287,580$603.92kInstitution
Rbf Capital LLC1.64%283,912$596.22kInstitution
Millennium Management LLC1.49%258,487$542.82kInstitution

1 of 3

MURA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MURA29.83%13.35%Net SellingNet Selling
TVRD7.84%92.16%Net Selling
PDSB11.47%24.13%Net Buying
PLUR0.04%99.96%Net Buying
SKYE2.73%97.27%Net Selling
View Top Biotech Stocks

Mural Oncology Stock Ownership FAQ

Who owns Mural Oncology?

Mural Oncology (NASDAQ: MURA) is owned by 29.83% institutional shareholders, 13.35% Mural Oncology insiders, and 56.82% retail investors. Trium Capital LLP is the largest individual Mural Oncology shareholder, owning 1.76M shares representing 10.15% of the company. Trium Capital LLP's Mural Oncology shares are currently valued at $3.68M.

If you're new to stock investing, here's how to buy Mural Oncology stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.